BACE1 and Alzheimer disease: To our knowledge, this is the first report of TAM B neuroprotective properties, reducing the toxicity of Aβ1–42, protecting the neuron from oxidative stress induced by serum deprivation and possessing anti-BACE1 activity, which position the compound to be used as multi-target anti-AD agents.